Experimentally validated novel inhibitors of Helicobacter pylori phosphopantetheine adenylyltransferase discovered by virtual high-throughput screening.
Helicobacter pylori is a major etiologic agent associated with the development and maintenance of human gastritis. The goal of this study was to develop novel antibiotics against H. pylori, and we thus targeted H. pylori phosphopantetheine adenylyltransferase (HpPPAT). PPAT catalyzes the penultimate...
Main Authors: | Chao-Sheng Cheng, Kai-Fan Jia, Ting Chen, Shun-Ya Chang, Ming-Shen Lin, Hsien-Sheng Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3764209?pdf=render |
Similar Items
-
A Fluorescence Polarization-Based High-Throughput Screen to Identify the First Small-Molecule Modulators of the Human Adenylyltransferase HYPE/FICD
by: Ali Camara, et al.
Published: (2020-09-01) -
High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2
by: Olujide O. Olubiyi, et al.
Published: (2020-07-01) -
Identification of the nicotinamide mononucleotide adenylyltransferase of Trypanosoma cruzi
by: Carlos H Niño, et al.
Published: (2015-11-01) -
Helicobacter pylori screening and gastric cancer.
by: Danesh, J, et al.
Published: (1996) -
4′‐Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN
by: Suh Young Jeong, et al.
Published: (2019-12-01)